tiprankstipranks
Definium Therapeutics (DFTX)
NASDAQ:DFTX
US Market
DFTX
Definium Therapeutics
RESEARCH TOOLSreports
Want to see DFTX full AI Analyst Report?

Definium Therapeutics (DFTX) Income Statement

2,293 Followers

Definium Therapeutics Income Statement

Last quarter (Q4 2025), Definium Therapeutics's total revenue was $0.00, a decrease of ― from the same quarter last year. In Q4, Definium Therapeutics's net income was $-50.44M. See Definium Therapeutics’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 25Dec 24Dec 23Dec 22Dec 21
Total Revenue
$ 0.00$ 0.00$ 0.00$ 0.00$ 0.00
Gross Profit
$ 0.00$ -527.00K$ -3.16M$ 0.00$ 0.00
Operating Expenses
$ 166.31M$ 103.39M$ 90.70M$ 66.33M$ 93.85M
Depreciation and Amortization
$ 0.00$ 527.00K$ 3.16M$ 3.18M$ 2.62M
EBITDA
$ -178.31M$ -105.87M$ -92.57M$ -63.15M$ -91.24M
Operating Income
$ -166.31M$ -103.92M$ -93.87M$ -66.33M$ -93.85M
Other Income/Expenses
$ -17.48M$ -4.76M$ -1.87M$ 9.54M$ -339.00K
Pretax Income
$ -183.79M$ -108.68M$ -95.73M$ -56.80M$ -94.19M
Net Income
$ -183.79M$ -108.68M$ -95.73M$ -56.80M$ -93.04M
Per Share Metrics
Basic EPS
$ -2.06$ -1.54$ -2.44$ -1.53$ -3.40
Diluted EPS
$ -2.06$ -0.15$ -2.44$ -1.53$ -3.40
Weighted Average Shares Outstanding
 89.33M 70.46M 39.16M 30.86M 27.38M
Weighted Average Shares Outstanding (Diluted)
 89.33M 704.61M 39.16M 30.86M 27.38M
Currency in USD

Definium Therapeutics Earnings and Revenue History